Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

Prana Biotechnology 2018 AGM Presentation

November 16, 2018August 16, 2022 Alterity Therapeutics

2018_11_16 AGM Presentation 2018

2018

Post navigation

Prana AGM Investor Conference Call

Life Biosciences LLC leads strategic investment of up to A$44.5 million in Prana

Related Posts

Alterity announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials

February 9, 2021August 16, 2022

Prana Biotechnology REACH2HD Investor Conference Call

February 18, 2014August 16, 2022

Dr David Stamler China Investor & Partnering Symposium Webcast

March 15, 2018August 16, 2022

Recent Posts

XBRL 30 June 2023 filed with the SEC
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065